Prime Medicine Inc (PRME)

May 28, 2026, 8:00 AM EDT - 2 days ago

Prime Medicine to Present at Jefferies Global Healthcare Conference

2026-05-07T19:46:03.000Z - 22 days ago

Prime Medicine reports Q1 EPS (28c), consensus (25c)

May 7, 2026, 8:00 AM EDT - 23 days ago

Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

May 7, 2026, 7:00 AM EDT - 23 days ago

Prime Medicine Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 23 days ago

Prime Medicine Earnings release: Q1 2026

2026-05-07T02:02:00.000Z - 23 days ago

Prime Medicine management to meet with Oppenheimer

Apr 23, 2026, 8:00 AM EDT - 5 weeks ago

Prime Medicine Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 5 weeks ago

Prime Medicine Proxy statement: Proxy filing

2026-04-16T12:25:29.000Z - 6 weeks ago

Prime Medicine appoints Makhni as Chief Financial Officer

Apr 16, 2026, 8:00 AM EDT - 6 weeks ago

Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer

2026-03-12T11:46:56.000Z - 2 months ago

Oppenheimer bullish on Prime Medicine, initiates with an Outperform

2026-03-12T10:26:58.000Z - 2 months ago

Prime Medicine initiated with an Outperform at Oppenheimer

Mar 11, 2026, 2:15 PM EDT - 2 months ago

Prime Medicine Transcript: The Citizens Life Sciences Conference 2026

Mar 4, 2026, 1:10 PM EST - 3 months ago

Prime Medicine Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-03T13:07:13.000Z - 3 months ago

Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year

Mar 3, 2026, 8:00 AM EST - 3 months ago

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

Mar 3, 2026, 8:00 AM EST - 3 months ago

Prime Medicine Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Prime Medicine Earnings release: Q4 2025

Mar 2, 2026, 7:00 AM EST - 3 months ago

Prime Medicine Slides: Corporate presentation

Feb 25, 2026, 8:00 AM EST - 3 months ago

Prime Medicine to Participate in Upcoming Investor Conferences

Jan 14, 2026, 12:00 PM EST - 4 months ago

Prime Medicine Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:00 PM EST - 4 months ago

Prime Medicine Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 5 months ago

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

2025-12-23T13:50:25.000Z - 5 months ago

Prime Medicine initiated with an Outperform at LifeSci Capital

2025-12-07T18:30:05.000Z - 6 months ago

Prime Medicine announces NEJM publication of PM359 data

Dec 7, 2025, 8:05 AM EST - 6 months ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Dec 2, 2025, 11:15 AM EST - 6 months ago

Prime Medicine Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 25, 2025, 8:00 AM EST - 6 months ago

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

2025-11-18T12:55:59.000Z - 6 months ago

Prime Medicine transferred with Neutral rating at JPMorgan

Nov 18, 2025, 7:00 AM EST - 6 months ago

Prime Medicine Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Transcript: KOL Event

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Press release: KOL Event

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prime Medicine Slides: KOL Event

2025-11-11T11:36:03.000Z - 7 months ago

Prime Medicine price target lowered to $4.25 from $5 at Citi

Nov 7, 2025, 10:21 AM EST - 7 months ago

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

2025-11-07T13:11:02.000Z - 7 months ago

Prime Medicine files automatic mixed securities shelf

2025-11-07T12:13:06.000Z - 7 months ago

Prime Medicine reports Q3 EPS (32c), consensus (25c)

Nov 7, 2025, 7:00 AM EST - 7 months ago

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 7, 2025, 7:00 AM EST - 7 months ago

Prime Medicine Quarterly report: Q3 2025

Nov 7, 2025, 7:00 AM EST - 7 months ago

Prime Medicine Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

Prime Medicine Slides: Corporate Presentation

2025-11-03T13:05:05.000Z - 7 months ago

Prime Medicine appoints Hawryluk as Chief Business Officer

Nov 3, 2025, 8:01 AM EST - 7 months ago

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Oct 30, 2025, 4:01 PM EDT - 7 months ago

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

2025-10-29T11:27:04.000Z - 7 months ago

Prime Medicine price target raised to $5 from $4 at Citi

Oct 21, 2025, 8:45 AM EDT - 7 months ago

Prime Medicine Transcript: Chardan’s 9th Annual Genetic Medicines Conference

Oct 14, 2025, 7:00 AM EDT - 8 months ago

Prime Medicine Transcript: H. C. Wainwright Genetic Medicines Virtual Conference

Sep 17, 2025, 7:00 AM EDT - 9 months ago

Prime Medicine Slides: Corporate Presentation

2025-09-11T00:45:09.000Z - 9 months ago

Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today

2025-09-10T04:14:10.000Z - 9 months ago

PRME, TWST, TEM: Cathie Wood Pours $1.9M Into Biotech, Cuts Stake in AI Stock

TEM TWST

Sep 8, 2025, 1:05 PM EDT - 9 months ago

Prime Medicine Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 2, 2025, 4:45 PM EDT - 9 months ago

Prime Medicine Transcript: Citi's Biopharma Back to School Conference

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Prime Medicine Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Prime Medicine Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 1, 2025, 4:01 PM EDT - 10 months ago

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Jul 30, 2025, 9:33 PM EDT - 10 months ago

Prime Medicine Announces Pricing of Public Offering

Jul 30, 2025, 4:01 PM EDT - 10 months ago

Prime Medicine Announces Proposed Public Offering of Common Stock

Jul 16, 2025, 8:10 AM EDT - 11 months ago

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

Jul 16, 2025, 7:00 AM EDT - 11 months ago

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Jul 14, 2025, 8:00 AM EDT - 11 months ago

Prime Medicine Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 11 months ago

Prime Medicine Proxy statement: Proxy Filing

Jun 25, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Slides: Corporate Presentation

Jun 5, 2025, 10:30 AM EDT - 1 year ago

Prime Medicine Transcript: Jefferies Global Healthcare Conference 2025

May 19, 2025, 8:31 AM EDT - 1 year ago

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

May 19, 2025, 8:30 AM EDT - 1 year ago

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

May 19, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing

May 8, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

May 8, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Earnings release: Q1 2025

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Prime Medicine Proxy statement: Proxy Filing

Mar 18, 2025, 7:00 AM EDT - 1 year ago

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Mar 3, 2025, 11:10 AM EST - 1 year ago

Prime Medicine Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 28, 2025, 8:00 AM EST - 1 year ago

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Feb 28, 2025, 8:00 AM EST - 1 year ago

Prime Medicine Annual report: Q4 2024

Feb 28, 2025, 8:00 AM EST - 1 year ago

Prime Medicine Earnings release: Q4 2024

Feb 24, 2025, 8:00 AM EST - 1 year ago

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Jan 30, 2025, 12:26 PM EST - 1 year ago

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Jan 14, 2025, 6:00 PM EST - 1 year ago

Prime Medicine Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 14, 2025, 6:00 PM EST - 1 year ago

Prime Medicine Slides: FY 2025

Dec 13, 2024, 7:00 AM EST - 1 year ago

Prime Medicine Registration statement: Registration Filing

Nov 21, 2024, 4:18 AM EST - 1 year ago

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics

Nov 19, 2024, 9:30 AM EST - 1 year ago

Prime Medicine Transcript: Jefferies London Healthcare Conference 2024

Nov 18, 2024, 1:15 PM EST - 1 year ago

Prime Medicine Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 3:00 PM EST - 1 year ago

Prime Medicine Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 12, 2024, 9:30 AM EST - 1 year ago

Prime Medicine Quarterly report: Q3 2024

Nov 12, 2024, 9:30 AM EST - 1 year ago

Prime Medicine Earnings release: Q3 2024

Oct 24, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Sep 30, 2024, 1:30 PM EDT - 1 year ago

Prime Medicine Transcript: Chardan 8th Annual Genetic Medicines Conference

Sep 30, 2024, 7:01 AM EDT - 1 year ago

Prime Medicine Unveils Strategically Focused Pipeline

Sep 4, 2024, 1:05 PM EDT - 1 year ago

Prime Medicine Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 8, 2024, 8:15 AM EDT - 1 year ago

Prime Medicine Quarterly report: Q2 2024

Aug 8, 2024, 8:15 AM EDT - 1 year ago

Prime Medicine Earnings release: Q2 2024

Jun 10, 2024, 2:00 PM EDT - 2 years ago

Prime Medicine Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 5, 2024, 1:30 PM EDT - 2 years ago

Prime Medicine Transcript: Jefferies 2024 Global Healthcare Conference

May 21, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing

May 20, 2024, 4:30 PM EDT - 2 years ago

Prime Medicine Transcript: H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 12, 2024, 3:00 AM EDT - 2 years ago

Alphabet Bought Up Two Slumping Stocks

GOOG GOOGL GTLB

May 10, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

May 10, 2024, 7:00 AM EDT - 2 years ago

Prime Medicine Quarterly report: Q1 2024

May 10, 2024, 7:00 AM EDT - 2 years ago

Prime Medicine Earnings release: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing

Apr 29, 2024, 7:00 AM EDT - 2 years ago

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Prime Medicine Proxy statement: Proxy Filing

Mar 6, 2024, 12:50 PM EST - 2 years ago

Prime Medicine Transcript: TD Cowen 44th Annual Health Care Conference 2024

Mar 1, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

Mar 1, 2024, 7:00 AM EST - 2 years ago

Prime Medicine Earnings release: Q4 2023

Mar 1, 2024, 7:00 AM EST - 2 years ago

Prime Medicine Annual report: Q4 2023

Feb 20, 2024, 4:01 PM EST - 2 years ago

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 14, 2024, 11:50 PM EST - 2 years ago

Prime Medicine Announces Pricing of Upsized Public Offering

Feb 8, 2024, 2:00 PM EST - 2 years ago

Prime Medicine Transcript: Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

Jan 25, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

Jan 25, 2024, 8:00 AM EST - 2 years ago

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Jan 8, 2024, 5:15 PM EST - 2 years ago

Prime Medicine Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 8, 2024, 5:15 PM EST - 2 years ago

Prime Medicine Slides: FY 2024

Jan 5, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Jan 2, 2024, 8:00 AM EST - 2 years ago

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

Nov 16, 2023, 8:30 AM EST - 2 years ago

Prime Medicine Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 14, 2023, 4:10 PM EST - 2 years ago

Prime Medicine Transcript: Stifel 2023 Annual Healthcare Conference

Nov 8, 2023, 8:00 AM EST - 2 years ago

Prime Medicine to Present at Upcoming Investor Conferences

Nov 3, 2023, 4:01 PM EDT - 2 years ago

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Quarterly report: Q3 2023

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Earnings release: Q3 2023

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine Registration statement: Registration Filing

Oct 27, 2023, 6:00 AM EDT - 2 years ago

Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b

Oct 24, 2023, 7:30 AM EDT - 2 years ago

Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases

Oct 17, 2023, 8:00 AM EDT - 2 years ago

Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences

Sep 27, 2023, 9:00 AM EDT - 2 years ago

Prime Medicine Transcript: Jefferies Cell & Genetic Medicine Summit

Sep 7, 2023, 4:00 PM EDT - 2 years ago

Prime Medicine Slides: Corporate Presentation

Aug 7, 2023, 4:01 PM EDT - 3 years ago

Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates

Aug 7, 2023, 7:00 AM EDT - 3 years ago

Prime Medicine Quarterly report: Q2 2023

Aug 7, 2023, 7:00 AM EDT - 3 years ago

Prime Medicine Earnings release: Q2 2023

Jun 22, 2023, 8:00 AM EDT - 3 years ago

Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome

Jun 12, 2023, 4:20 PM EDT - 3 years ago

Prime Medicine Transcript: Goldman Sachs 44th Annual Global Healthcare Conference

May 31, 2023, 8:00 AM EDT - 3 years ago

Prime Medicine to Present at Investor Conferences in June